Study Shows Medtronic Neurostimulation Therapy Improves Chronic Neuropathic Leg And Back Pain

Offering hope to millions of chronic pain sufferers around the world, a major study published online by the international medical journal PAIN and supported by Medtronic, Inc. (NYSE: MDT) found that people with chronic neuropathic leg and back pain benefited significantly more from neurostimulation therapy plus conventional medical management than from conventional medical management alone.


The study, known as PROCESS (for PROspective randomized Controlled trial of the Effectiveness of Spinal cord Stimulation), showed that Medtronic neurostimulation therapy plus conventional medical management provided patients with significantly greater pain relief, quality of life, functional capacity and treatment satisfaction than conventional medical management alone after six months. Importantly, 48 percent of the patients assigned to receive neurostimulation plus conventional treatments experienced a 50 percent or greater improvement in leg pain compared to 9 percent of patients assigned to receive only conventional treatments (p